Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Aug 12, 2023
targetedonc.com
In breast cancer, over 40% of HR cases have PIK3CA mutations, driving overactive PI3K signaling that fuel cancer growth. Marie-Gabrielle Braun, Senior Principal Scientist & Project Leader at Genentech, uses everyday objects to explain how cancer therapies are becoming more precise in going after mutated pathways, enabling new ways to fight back while sparing healthy cells. | Genentech
1:30
In breast cancer, over 40% of HR cases have PIK3CA mutations, driving overactive PI3K signaling that fuel cancer growth. Marie-Gabrielle Braun, Senior Principal Scientist & Project Leader at Genentech, uses everyday objects to explain how cancer therapies are becoming more precise in going after mutated pathways, enabling new ways to fight back while sparing healthy cells. | Genentech
359.8K viewsNov 13, 2024
FacebookGenentech
When ESR1 and PIK3CA co-mutations are both present in HR+/HER2– metastatic breast cancer, there is no clear guideline on which to target first. A senior breast oncologist at an NCI-affiliated… | Global Oncology Leadership Forum (GOLF)
When ESR1 and PIK3CA co-mutations are both present in HR+/HER2– metastatic breast cancer, there is no clear guideline on which to target first. A senior breast oncologist at an NCI-affiliated… | Global Oncology Leadership Forum (GOLF)
1 views3 weeks ago
linkedin.com
PIK3CA is the most commonly mutated gene in ~40% of patients with HR /HER2- breast cancer. Learn more about the PIK3CA mutation, how it may affect your cancer care and questions to ask your doctor about testing for mutations. #ASCO21 https://bddy.me/2T20ydO | Novartis Cancer
0:11
PIK3CA is the most commonly mutated gene in ~40% of patients with HR /HER2- breast cancer. Learn more about the PIK3CA mutation, how it may affect your cancer care and questions to ask your doctor about testing for mutations. #ASCO21 https://bddy.me/2T20ydO | Novartis Cancer
482 viewsJun 5, 2021
FacebookNovartis Cancer
PIK3CA Mutations in Breast Cancer Explained
0:46
PIK3CA Mutations in Breast Cancer Explained
1.6K views5 months ago
YouTubeYerbba – Breast Cancer
Breast cancer is one of the most common cancers in women, often caused by mutations in the PI3K pathway. One of the key mutations in this pathway is in the PIK3CA gene, which is found in about 40% of HR cases. Using everyday objects, Marie-Gabrielle Braun, Senior Principal Scientist & Project Leader at Genentech, explains how cancer therapies are becoming more precise in targeting this elusive pathway. Learn more about PIK3CA in breast cancer and watch the full video series: http://spr.ly/6188sJ
2:17
Breast cancer is one of the most common cancers in women, often caused by mutations in the PI3K pathway. One of the key mutations in this pathway is in the PIK3CA gene, which is found in about 40% of HR cases. Using everyday objects, Marie-Gabrielle Braun, Senior Principal Scientist & Project Leader at Genentech, explains how cancer therapies are becoming more precise in targeting this elusive pathway. Learn more about PIK3CA in breast cancer and watch the full video series: http://spr.ly/6188sJ
304 viewsNov 13, 2024
FacebookGenentech
Module 1 PIK3CA Mutations in Breast Cancer
0:59
Module 1 PIK3CA Mutations in Breast Cancer
24 views4 months ago
VimeoAnnenberg Center
7:27
Breast Cancer Mutations: BRCA1, BRCA2, CHEK2, TP53, ESR1, PIK3CA, MAP3K1 (COMPLETE Guide)
2.7K views8 months ago
YouTubeYerbba – Breast Cancer
12:55
Molecular Tumor Board Series - Breast Cancer with ESR1 and PIK3CA mutations
833 viewsNov 28, 2022
YouTubeCirculogene
15:46
Targeting PIK3CA Mutations in HR+/HER2- Breast Cancer: New Insights from ReDiscover
7 views5 months ago
YouTubeReachMD
1:50
The PI3K Signaling Pathway
154.1K viewsNov 13, 2012
YouTubeGenentech
1:08
PIK3CA Mutation and T-DXd in HER2 Positive Breast Cancer
159 views4 months ago
YouTubePrecision Cancer News
6:46
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
7 views7 months ago
YouTubeReachMD
3:06
Why Do Cancers Have PIK3CA Mutations and How Can They Be Targeted for Cancer Treatment?
1.2K viewsSep 21, 2023
YouTubeMedical-Question
15:01
Domain-specific PIK3CA mutations affect different pathway activities... - Christopher Benz
3.9K viewsMay 23, 2014
YouTubeNational Human Genome Research Institute
1:07
ESR1 & PIK3CA Mutations Impact Breast Cancer Outcomes
145 views4 months ago
YouTubeThe Oncology Brief
2:41
Genetics of PIK3CA Mutation
1.1K views2 months ago
YouTubeDr. Rob Swanda
1:59
Dr. Hurvitz on Patient Outcomes and PIK3CA Mutations
1.6K viewsJul 18, 2014
YouTubeTargeted Oncology
7:08
Pi3k Pathway
68.7K viewsJun 15, 2015
YouTubeShomu's Biology
1:11
PIK3CA and HER2 Resistance in Breast Cancer: Expert Insights
164 views4 months ago
YouTubePrecision Cancer News
46:29
Oncogene additivity in the PI3K pathway in cancer
1.5K viewsDec 1, 2020
YouTubeLabroots
26:17
The PI3K / AKT / mTOR Pathway and Cancer Part 5
4.2K viewsMay 1, 2015
YouTubeElliot Nicholson
1:27
Deciphering the Role of PI3K Mutations in HER2+ Breast Cancer
5.8K viewsJul 26, 2017
YouTubeASCOcancer
5:21
PI3K Pathway Inhibitors: Safety and Tolerability Profiles
7 months ago
reachmd.com
3:01
【乳癌的潛在真相】降低乳癌患者存活率的基因變異 – PIK3CA
2.6K viewsMar 4, 2021
YouTubeHK Breast Cancer Foundation
4:20
PIK3CA Mutations in HER2-Positive Breast Cancer
3.5K viewsFeb 10, 2014
YouTubeOncLive
8:07
New Study Guardant360® liquid biopsy test - PIK3CA Mutations
1.1K viewsMay 17, 2020
YouTubeHPR
8:28
pi3k/akt/mtor pathway
106.7K viewsJun 15, 2015
YouTubeShomu's Biology
9:11
Perspectives on a Patient with ESR1m and PIK3CA Mutations
63 views3 months ago
YouTubeORSERDU® (elacestrant) HCP
5:46
PI3K Pathway Inhibitors: Safety and Tolerability Profiles
5 views7 months ago
YouTubeReachMD
See more
Static thumbnail place holder